Our studies employing two different cell models of the F508del-CFTR mutated protein, began to reveal the role of IGFBP-6 in the CF-associated inflammation in CFBE cell lines and in patient-derived, nasal epithelial cultures. Here, IGFBP6 is linked to cystic fibrosis.